Abstract
The ability of anaerobic bacteria to cause disease in humans and animals has been recognized for many years. The clostridia, for example, are well known for their ability to cause disease by producing a variety of toxins ranging from the potent neurotoxins of Clostridium tetani and Clostridium botulinum to the tissue-damaging toxins of the gas gangrene clostridia. Bacteroides fragilis, on the other hand, represents the major anaerobic pathogen in clinical specimens from patients with abscesses and soft-tissue infections. More recently, the importance of members of these genera in gastrointestinal infections has become recognized. Clostridium difficile has emerged as the major cause of nosocomial diarrhea because of its ability to produce diarrhea and pseudomembranous colitis in patients treated with antibiotics. Clostridium perfringens, which is the major cause of gas gangrene, produces a diverse group of toxins that are involved in enteric disease. In industrialized countries, outbreaks of C. perfringens food poisoning occur because of the production of a spore-associated enterotoxin. In certain regions in the Pacific rim, especially in Papua New Guinea, a disease known as pigbel, which is prevalent in persons who eat improperly cooked pork, results from infection with C. perfringens type C strains that produce β-toxin. In addition to these maladies, type E strains of C. perfringens and certain strains of Clostridium spiroforme produce a toxin (iota) that results in another distinctive type of enterotoxemia in animals.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Borriello, S. P., 1985, Clostridia in Gastrointestinal Disease, CRC Press, Boca Raton, FL.
Finegold, S. M., and George, W. L., 1989, Anaerobic Infections in Humans, Academic Press, San Diego.
Hatheway, C. L., 1990, The toxigenic Clostridia, Clin. Microbiol. Rev. 3:66–98.
McClane, B. A., Hann, P. C., and Wnek, A. P., 1988, Clostridium perfringens enterotoxin, Microb. Pathog. 4:317–323.
Rolfe, R. D., and Finegold, S. M., 1988, Clostridium difficile: Its Role in Intestinal Disease, Academic Press, San Diego.
Rood, J. I., and Cole, S. T., 1991, Molecular genetics and pathogenesis of Clostridium perfringens, Microbiol. Rev. 55:621–648.
Sebald, M., 1992, Genetics and Molecular Biology of Anaerobic Bacteria, Springer-Verlag, Berlin.
References
Rolfe, R. D., and Finegold, S. M., 1988, Clostridium difficile: Its Role in Intestinal Disease, Academic Press, San Diego.
McFarland, L. V., Mulligan, M. E., Kwok, R. Y. Y., and Stamm, W. E., 1991, Nosocomial acquisition of Clostridium difficile infection, N. Engl. J. Med. 320:204–210.
Lyerly, D. M., and Wilkins, T. D., 1991, Toxins of anaerobes, in: Anaerobic Microbiology, a Practical Approach (P. N. Levett, ed.), IRL Press, New York, pp. 163–181.
Just, I., Fritz, G., Aktories, K., Giry, M., Popoff, M., Boquet, P., Hegenbarth, S., and von Eichel-Streiber, C., 1994, Clostridium difficile toxin B acts on the GTP-binding protein rho, J. Biol. Chem. 269:10706–10712.
Dove, C. H., Wang, S.-Z., Price, S. B., Phelps, C. J., Lyerly, D. M., Wilkins, T. D., and Johnson, J. L., 1990, Molecular characterization of the Clostridium difficile toxin A gene, Infect. Immun. 58:480–488.
Barroso, L. A., Wang, S.-Z., Phelps, C. J., Johnson, J. L., and Wilkins, T. D., 1990, Nucleotide sequence of Clostridium difficile toxin B gene, Nucl. Adds Res. 18:4004.
Martinez, R. D., and Wilkins, T. D., 1992, Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of Clostridium difficile, J. Med. Microbiol. 36:30–36.
Lyerly, D. M., Phelps, C. J., Toth, J., and Wilkins, T. D., 1986, Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies, Infect. Immun. 54:70–76.
Van Damme-Jongsten, M., Rodhouse, J., Gilbert, R. J., and Notermans, S., 1990, Synthetic DNA probes for detection of enterotoxigenic Clostridium perfringens strains isolated from outbreaks of food poisoning, J. Clin. Microbiol. 28:131–133.
Duncan, C. L., and Strong, D. H., 1968, Improved medium for sporulation of Clostridium perfringens, Appl. Microbiol. 16:82–89.
Hanna, P. C., Wieckowski, E. U., Mietzner, T. A., and McClane, B. A., 1992, Mapping of functional regions of Clostridium perfringens type A enterotoxin, Infect. Immun. 60:2110–2114.
Granum, P. E., and Stewart, G. S. A. B., 1992, Molecular biology of Clostridium perfringens enterotoxin, in: Genetics and Molecular Biology of Anaerobic Bacteria (M. Sebald, ed.) Springer-Verlag, Berlin, pp. 235–247.
Sakurai, J., and Fujii, U., 1987, Purification and characterization of Clostridium perfringens beta toxin, Toxicon 25:1301–1310.
Finegold, S. M., and George, W. L., 1989, Anaerobic Infections in Humans, Academic Press, San Diego.
Stiles, B. G., and Wilkins, T. D., 1986, Clostridium perfringens iota toxin: Synergism between two proteins, Toxicon 24:767–773.
Stiles, B. G., and Wilkins, T. D., 1986, Purification and characterization of Clostridium perfringens iota toxin: Dependence on two nonlinked proteins for biological activity, Infect. Immun. 54:683–688.
Popoff, M. R., and Bouquet, P., 1988, Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin, Biochem. Biophys. Res. Commun. 152:1361–1368.
Carman, R. J., Van Tassell, R. L., and Wilkins, T. D., 1987, Production of iota toxin by Clostridium spiroforme. A requirement for divalent cations, Vet. Microbiol. 15:115–120.
Popoff, M. R., Rubin, E. J., Gill, D. M., and Boquet, P., 1988, Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain, Infect. Immun. 56:2299–2306.
Perelle, S., Gibert, M., Boquet, P., and Popoff, M. R., 1993, Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli, Infect. Immun. 61:5147–5156.
Sack, R. B., Albert, M. J., Alam, K., Neogi, P. K. B., and Akbar, M. S., 1994, Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: A controlled study, J. Clin. Microbiol. 32:960–963.
Weikel, C. S., Grieco, E D., Reuben, J., Myers, L. L., and Sack, R. B., 1992, Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology, Infect. Immun. 60:321–327.
Van Tassell, R. L., Lyerly, D. M., and Wilkins, T. D., 1992, Purification and characterization of an enterotoxin from Bacteroides fragilis, Infect. Immun. 60:1343–1350.
Moncrief, J. S., and Van Tassell, R. L., personal communication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lyerly, D.M., van Tassell, R.L., Wilkins, T.D. (1996). Clostridia and Bacteroides in Enteric Infections. In: Paradise, L.J., Bendinelli, M., Friedman, H. (eds) Enteric Infections and Immunity. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0313-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0313-6_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0315-0
Online ISBN: 978-1-4899-0313-6
eBook Packages: Springer Book Archive